An Enhanced Hybrid Screening Approach to Identify Potent Inhibitors for the SARS-CoV-2 Main Protease From the NCI Compound Library

por Li, Shuhua G., Yang, Kai S., Blankenship, Lauren R., Cho, Chia-Chuan D., Xu, Shiqing, Wang, Hongbin, Liu, Wenshe Ray
Publicado 2022

Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease

por Yang, Kai S., Alex Kuo, Syuan-Ting, Blankenship, Lauren R., Geng, Zhi Zachary, Li, Shuhua G., Russell, David H., Yan, Xin, Xu, Shiqing, Liu, Wenshe Ray
Publicado 2022

A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals

por Ma, Yuying, Yang, Kai S., Geng, Zhi Zachary, Alugubelli, Yugendar R., Shaabani, Namir, Vatansever, Erol C., Ma, Xinyu R., Cho, Chia-Chuan, Khatua, Kaustav, Xiao, Jing, Blankenship, Lauren R., Yu, Ge, Sankaran, Banumathi, Li, Pingwei, Allen, Robert, Ji, Henry, Xu, Shiqing, Liu, Wenshe Ray
Publicado 2022

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals

por Alugubelli, Yugendar R., Geng, Zhi Zachary, Yang, Kai S., Shaabani, Namir, Khatua, Kaustav, Ma, Xinyu R., Vatansever, Erol C., Cho, Chia-Chuan, Ma, Yuying, Xiao, Jing, Blankenship, Lauren R., Yu, Ge, Sankaran, Banumathi, Li, Pingwei, Allen, Robert, Ji, Henry, Xu, Shiqing, Liu, Wenshe Ray
Publicado 2022